Change search
ReferencesLink to record
Permanent link

Direct link
Ectopic expression of the chemokine CXCL17 in colon cancer cells
Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Immunology/Immunchemistry.
Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Immunology/Immunchemistry. (Marie-Louise Hammarström)
Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Immunology/Immunchemistry.
Show others and affiliations
2016 (English)In: British Journal of Cancer, ISSN 0007-0920, E-ISSN 1532-1827, Vol. 114, no 6, 697-703 p.Article in journal (Refereed) PublishedText
Abstract [en]

Background: The novel chemokine CXCL17 acts as chemoattractant for monocytes, macrophages and dendritic cells. CXCL17 also has a role in angiogenesis of importance for tumour development. Methods: Expression of CXCL17, CXCL10, CXCL9 and CCL2 was assessed in primary colon cancer tumours, colon carcinoma cell lines and normal colon tissue at mRNA and protein levels by real-time qRT-PCR, immunohistochemistry, two-colour immunofluorescence and immunomorphometry. Results: CXCL17 mRNA was expressed at 8000 times higher levels in primary tumours than in normal colon (P<0.0001). CXCL17 protein was seen in 17.2% of cells in tumours as compared with 0.07% in normal colon (P = 0.0002). CXCL10, CXCL9 and CCL2 mRNAs were elevated in tumours but did not reach the levels of CXCL17. CXCL17 and CCL2 mRNA levels were significantly correlated in tumours. Concordant with the mRNA results, CXCL10-and CXCL9-positive cells were detected in tumour tissue, but at significantly lower numbers than CXCL17. Two-colour immunofluorescence and single-colour staining of consecutive sections for CXCL17 and the epithelial cell markers carcinoembryonic antigen and BerEP4 demonstrated that colon carcinoma tumour cells indeed expressed CXCL17. Conclusions: CXCL17 is ectopically expressed in primary colon cancer tumours. As CXCL17 enhances angiogenesis and attracts immune cells, its expression could be informative for prognosis in colon cancer patients.

Place, publisher, year, edition, pages
2016. Vol. 114, no 6, 697-703 p.
Keyword [en]
CXCL17, CXCL10, CXCL9, CCL2, colon cancer, prognosis, immunomorphometry, qRT-PCR
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-119285DOI: 10.1038/bjc.2016.4ISI: 000372523500013PubMedID: 26889977OAI: diva2:928831
Available from: 2016-05-16 Created: 2016-04-15 Last updated: 2016-05-30Bibliographically approved

Open Access in DiVA

fulltext(1868 kB)55 downloads
File information
File name FULLTEXT01.pdfFile size 1868 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Ohlsson, LinaHammarström, Marie-LouiseHammarström, StenSitohy, Basel
By organisation
In the same journal
British Journal of Cancer
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 55 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 50 hits
ReferencesLink to record
Permanent link

Direct link